The National Vaccine Institute (NVI), in partnership with the Africa Centres for Disease Control and Prevention (Africa CDC) and the African Vaccine Manufacturing Initiative (AVMI), has successfully co-hosted a high-level convening of African vaccine manufacturers and technology transfer experts in Accra this week.
The gathering brought together key stakeholders to strategize on accelerating the continent’s ability to develop and manufacture its own vaccines.
The sessions focused on overcoming the technical barriers that often hinder local production. During the convening, participants achieved two critical milestones:
-
Refined Guidelines: The group worked to refine practical guidelines for technology transfers, ensuring they are tailored to meet the unique operational and infrastructural needs of African manufacturers.
-
African Tech Transfer Database: Stakeholders explored modalities for establishing a continental Tech Transfer Database. Once operational, this database will serve as a vital resource for players in the vaccine R&D and manufacturing space, facilitating easier access to critical data and partnerships.
Speaking on the platform, NVI Chief Executive Officer, Dr. Sodzi Sodzi-Tettey, provided a comprehensive update on Ghana’s strides in vaccine research, development, and manufacturing.
Dr. Sodzi-Tettey highlighted that these achievements have been made possible through the unwavering political commitment of His Excellency President John Dramani Mahama and the strategic leadership of the Minister of Health, Hon. Kwabena Mintah Akandoh.
The convening concluded with a renewed pledge from all partners to prioritize collaboration. The NVI remains steadfast in its commitment to driving innovation and securing vaccine independence for Ghana and the wider African continent.